Analyst coverage
Royalty Pharma coverage analysts and the institutions they represent
Royalty Pharma plc (Nasdaq: RPRX) is covered by the following analysts.
| Institution | Contact |
|---|---|
| Bank of America Merrill Lynch | Charlie Yang |
| Citi | Peter Verdult |
| Evercore ISI | Umer Raffat |
| Goldman Sachs | Chris Shibutani |
| J.P. Morgan | Chris Schott |
| Morgan Stanley | Terence Flynn |
| Morningstar | Rachel Elfman |
| TD Cowen | Steve Scala |
| Tigress Financial Partners | Ivan Feinseth |
| UBS | Ashwani Verma |
Royalty Pharma is followed by the analysts listed above as of September 2024. Royalty Pharma believes the list to be complete, but can provide no assurances. The list above may change as firms initiate or discontinue coverage. Please note that any statements, opinions, estimates or forecasts regarding Royalty Pharma’s performance made by these analysts are theirs alone and do not represent statements, opinions, forecasts or predictions of Royalty Pharma or its management. Royalty Pharma does not by its reference above or distribution imply its endorsement of, adoption or concurrence with such information, conclusions or recommendations. Moreover, Royalty Pharma does not and will not distribute copies of analysts’ reports to investors or other persons.
